BCLI EV/EBITDA
-0.95
+0.14+12.84%
Thu, 23 Jan 2025 00:20:19 GMT
Summary:
As of January 23, 2025, BCLI EV/EBITDA is -0.95, with a rise of +0.14 (+12.84%) during the most recent trading day. Over the past year, it has dropped by -0.12 (-14.46%). BCLI EV/EBITDA is now -137.50% below its all-time high of -0.40.BCLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCLI EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +12.8% |
| 1 m1 month | +9.5% |
| 3 m3 months | -1.1% |
| 6 m6 months | +41.7% |
| ytdytd | +2.1% |
| 1 y1 year | -14.5% |
| 5 y5 years | +78.5% |
BCLI EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -0.86 | -10.5% | -1.19 | +20.2% |
| 3 m | 3-month | -0.54 | -75.9% | -1.19 | +20.2% |
| 6 m | 6-month | -0.54 | -75.9% | -1.73 | +45.1% |
| 1 y | 1-year | -0.54 | -75.9% | -2.76 | +65.6% |
| 3 y | 3-year | -0.40 | -137.5% | -6.29 | +84.9% |
| 5 y | 5-year | -0.40 | -137.5% | -19.40 | +95.1% |
| alltime | all time | -0.40 | -137.5% | -27.87 | +96.6% |
Brainstorm Cell Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.95(-2.1%) |
| 2024 | -0.97(+26.0%) |
| 2023 | -0.77(-70.3%) |
| 2022 | -2.59(-52.3%) |
| 2021 | -5.43(+32.8%) |
| 2020 | -4.09(-7.5%) |
| 2019 | -4.42(-15.2%) |
| 2018 | -5.21(-64.4%) |
| 2017 | -14.63(+56.1%) |
| Date | Value |
|---|---|
| 2016 | -9.37(+50.2%) |
| 2015 | -6.24(-32.4%) |
| 2014 | -9.23(+64.8%) |
| 2013 | -5.60(-37.8%) |
| 2012 | -9.01(+45.3%) |
| 2011 | -6.20(-21.1%) |
| 2010 | -7.86(-31.9%) |
| 2009 | -11.55(+761.9%) |
| 2008 | -1.34 |
FAQ
- What is Brainstorm Cell Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Brainstorm Cell Therapeutics?
- What is BCLI EV/EBITDA year-to-date change?
- What is Brainstorm Cell Therapeutics EV/EBITDA year-on-year change?
What is Brainstorm Cell Therapeutics EV/EBITDA?
The current EV/EBITDA of BCLI is -0.95
What is the all time high EV/EBITDA for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high EV/EBITDA is -0.40
What is BCLI EV/EBITDA year-to-date change?
Brainstorm Cell Therapeutics EV/EBITDA has changed by +0.02 (+2.06%) since the beginning of the year
What is Brainstorm Cell Therapeutics EV/EBITDA year-on-year change?
Over the past year, BCLI EV/EBITDA has changed by -0.12 (-14.46%)